BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre; randomised; phase 2 trial.

Keil F; Müller AMS; Berghold A; Riedl R; Buxhofer-Ausch V; Schuster J; Vorburger C; Böhm A; Panny M; Nösslinger T; Greil R; Samaras P; Bencker C; Rütti M; Pabst T.

EClinicalMedicine. 2023 Nov 19:66:102318.  doi: 10.1016/j.eclinm.2023.102318. eCollection 2023 Dec.

https://pubmed.ncbi.nlm.nih.gov/38024477/